Report ID: PMRREP33993
Number of Pages: 228
Format: PPT*, PDF, EXCEL
Industry: Healthcare
Published Date: February-2024
1. Executive Summary
1.1. Global Neurorehabilitation Devices Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. Neurorehabilitation Devices Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force’s Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Neurorehabilitation Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Neurorehabilitation Devices Market Outlook: Product
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
3.3.3.1. Neurorobotic Systems
3.3.3.2. Brain Computer Interface
3.3.3.3. Wearable Devices
3.3.3.4. Brain Stimulators
3.4. Market Attractiveness Analysis: Product
3.5. Global Neurorehabilitation Devices Market Outlook: End User
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
3.5.3.1. Rehabilitation Centers
3.5.3.2. Hospitals & Clinics
3.5.3.3. Home Care
3.5.3.4. Others
3.6. Market Attractiveness Analysis: End User
3.7. Global Neurorehabilitation Devices Market Outlook: Application
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
3.7.3.1. Stroke
3.7.3.2. Parkinson’s Disease
3.7.3.3. Brain & Spinal Cord Injury
3.7.3.4. Cerebral Palsy
3.7.3.5. Multiple Sclerosis
3.7.3.6. Others
3.8. Market Attractiveness Analysis: Application
4. Global Neurorehabilitation Devices Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Neurorehabilitation Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Product
5.3.3. By End User
5.3.4. By Application
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
5.5.1. Neurorobotic Systems
5.5.2. Brain Computer Interface
5.5.3. Wearable Devices
5.5.4. Brain Stimulators
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
5.6.1. Rehabilitation Centers
5.6.2. Hospitals & Clinics
5.6.3. Home Care
5.6.4. Others
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
5.7.1. Stroke
5.7.2. Parkinson’s Disease
5.7.3. Brain & Spinal Cord Injury
5.7.4. Cerebral Palsy
5.7.5. Multiple Sclerosis
5.7.6. Others
5.8. Market Attractiveness Analysis
6. Europe Neurorehabilitation Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Product
6.3.3. By End User
6.3.4. By Application
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
6.5.1. Neurorobotic Systems
6.5.2. Brain Computer Interface
6.5.3. Wearable Devices
6.5.4. Brain Stimulators
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
6.6.1. Rehabilitation Centers
6.6.2. Hospitals & Clinics
6.6.3. Home Care
6.6.4. Others
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
6.7.1. Stroke
6.7.2. Parkinson’s Disease
6.7.3. Brain & Spinal Cord Injury
6.7.4. Cerebral Palsy
6.7.5. Multiple Sclerosis
6.7.6. Others
6.8. Market Attractiveness Analysis
7. East Asia Neurorehabilitation Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Product
7.3.3. By End User
7.3.4. By Application
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
7.5.1. Neurorobotic Systems
7.5.2. Brain Computer Interface
7.5.3. Wearable Devices
7.5.4. Brain Stimulators
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
7.6.1. Rehabilitation Centers
7.6.2. Hospitals & Clinics
7.6.3. Home Care
7.6.4. Others
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
7.7.1. Stroke
7.7.2. Parkinson’s Disease
7.7.3. Brain & Spinal Cord Injury
7.7.4. Cerebral Palsy
7.7.5. Multiple Sclerosis
7.7.6. Others
7.8. Market Attractiveness Analysis
8. South Asia & Oceania Neurorehabilitation Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Product
8.3.3. By End User
8.3.4. By Application
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
8.5.1. Neurorobotic Systems
8.5.2. Brain Computer Interface
8.5.3. Wearable Devices
8.5.4. Brain Stimulators
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
8.6.1. Rehabilitation Centers
8.6.2. Hospitals & Clinics
8.6.3. Home Care
8.6.4. Others
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
8.7.1. Stroke
8.7.2. Parkinson’s Disease
8.7.3. Brain & Spinal Cord Injury
8.7.4. Cerebral Palsy
8.7.5. Multiple Sclerosis
8.7.6. Others
8.8. Market Attractiveness Analysis
9. Latin America Neurorehabilitation Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Product
9.3.3. By End User
9.3.4. By Application
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
9.5.1. Neurorobotic Systems
9.5.2. Brain Computer Interface
9.5.3. Wearable Devices
9.5.4. Brain Stimulators
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
9.6.1. Rehabilitation Centers
9.6.2. Hospitals & Clinics
9.6.3. Home Care
9.6.4. Others
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
9.7.1. Stroke
9.7.2. Parkinson’s Disease
9.7.3. Brain & Spinal Cord Injury
9.7.4. Cerebral Palsy
9.7.5. Multiple Sclerosis
9.7.6. Others
9.8. Market Attractiveness Analysis
10. Middle East & Africa Neurorehabilitation Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Product
10.3.3. By End User
10.3.4. By Application
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
10.5.1. Neurorobotic Systems
10.5.2. Brain Computer Interface
10.5.3. Wearable Devices
10.5.4. Brain Stimulators
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
10.6.1. Rehabilitation Centers
10.6.2. Hospitals & Clinics
10.6.3. Home Care
10.6.4. Others
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
10.7.1. Stroke
10.7.2. Parkinson’s Disease
10.7.3. Brain & Spinal Cord Injury
10.7.4. Cerebral Palsy
10.7.5. Multiple Sclerosis
10.7.6. Others
10.8. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Analog IC
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Neofect
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Boston Scientific Corporation
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. AlterG Inc.
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Eodyne
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Medtronic plc
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Biometrics Ltd.
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Bioness Inc.
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Kinestica
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Hocoma AG
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. BIONIK Laboratories Corp.
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. Ekso Bionics Holdings Inc.
11.3.11.1. Overview
11.3.11.2. Segments and Product
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations